Baker Bros. Advisors LP Uro Gen Pharma Ltd. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$16.5 - $29.7 $11.1 Million - $20 Million	-672,912 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.68 - $34.6 $2.17 Million - $5.49 Million	-158,576 Reduced 19.07%	672,912 $12 Million
Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $1.77 Million - $2.92 Million	83,737 Added 11.2%	831,488 $27.7 Million
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $17.8 Million - $27.2 Million	747,751 New	747,751 $17.8 Million

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $244M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.